Related references
Note: Only part of the references are listed.Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease
Omidvar Rezaei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
The interaction between miRNAs/lncRNAs and nuclear factor-?B (NF-?B) in human disorders
Soudeh Ghafouri-Fard et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols
Saumitra Sen Singh et al.
NEUROTOXICITY RESEARCH (2020)
LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway
Jingjing Jiang et al.
AGING-US (2020)
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease
Arianna Bellucci et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3
Yong Zhang et al.
NEUROCHEMICAL RESEARCH (2020)
Expression of NF-κB associated lncRNAs in schizophrenia
Amin Safa et al.
SCIENTIFIC REPORTS (2020)
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1
Chen-Hong Ding et al.
MOLECULAR CANCER (2018)
A Parkinson's disease gene, DJ-1, regulates astrogliosis through STAT3
Dong-Joo Choi et al.
NEUROSCIENCE LETTERS (2018)
Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinson's disease
Zhan-ying Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation
Bozena Kaminska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Xue Wang et al.
JOURNAL OF HEPATOLOGY (2016)
NFκB is a central regulator of protein quality control in response to protein aggregation stresses via autophagy modulation
Mathieu Nivon et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α
Chunyang Bao et al.
SCIENCE SIGNALING (2015)
NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α
Chunyang Bao et al.
SCIENCE SIGNALING (2015)
Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells
Xue Yang et al.
GUT (2014)
p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes
Michal Krawczyk et al.
ELIFE (2014)
A NETWORK VIEW ON PARKINSON'S DISEASE
Sreedevi Chandrasekaran et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Crosstalk of reactive oxygen species and NF-kappa B signaling
Michael J. Morgan et al.
CELL RESEARCH (2011)
Transcriptional Factor NF-kappa B as a Target for Therapy in Parkinson's Disease
Patrick M. Flood et al.
PARKINSONS DISEASE (2011)
NF-kappa B p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia
Ilenia Sarnico et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Leptin as a neuroprotective agent
Bor Luen Tang
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Bim and Noxa are candidates to mediate the deleterious effect of the NF-κB subunit RelA in cerebral ischemia
Ioana Inta et al.
JOURNAL OF NEUROSCIENCE (2006)
Share Paper
